We are live on
!
Find out more
BRA
Bender Robert & Associates Portfolio holdings
AUM
$481M
1-Year Est. Return
35.73%
This Fund
S&P 500
This Quarter
Est. Return
0%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$455M
AUM Growth
+$28.6M
(+6.7%)
Cap. Flow
-$433M
Cap. Flow
% of AUM
-95.16%
Top 10 Holdings %
Top 10 Hldgs %
76.35%
Holding
84
New
41
Increased
–
Reduced
–
Closed
43
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$79.8M |
| 2 |
NVIDIA
NVDA
|
+$74.2M |
| 3 |
Intuitive Surgical
ISRG
|
+$35M |
| 4 |
Amazon
AMZN
|
+$27.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 100% |
| 2 | Communication Services | 0% |
| 3 | Consumer Discretionary | 0% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
Gilead Sciences
GILD
$181B
| $1.28M | 0.28% |
+18,713
| New | +$1.25M |
|
27
PUT
AbbVie
ABBV
$463B
| $1.28M | 0.28% |
+7,466
| New | +$1.24M |
|
28
PUT
Costco
COST
$408B
| $1.24M | 0.27% |
+1,464
| New | +$1.14M |
|
29
PUT
Bristol-Myers Squibb
BMY
$131B
| $1.01M | 0.22% |
+24,307
| New | +$1.09M |
|
30
PUT
Merck
MRK
$358B
| $661K | 0.15% |
+5,343
| New | +$688K |
|
31
PUT
JPMorgan Chase
JPM
$931B
| $631K | 0.14% |
+3,122
| New | +$610K |
|
32
PUT
Abbott
ABT
$178B
| $604K | 0.13% |
+5,811
| New | +$616K |
|
33
PUT
Paychex
PAYX
$42.1B
| $552K | 0.12% |
+4,655
| New | +$569K |
|
34
PUT
Johnson & Johnson
JNJ
$646B
| $523K | 0.11% |
+3,578
| New | +$532K |
|
35
PUT
Nucor
NUE
$57.7B
| $396K | 0.09% |
+2,505
| New | +$435K |
|
36
PUT
Deere & Co
DE
$183B
| $383K | 0.08% |
+1,025
| New | +$400K |
|
37
PUT
Caterpillar
CAT
$362B
| $379K | 0.08% |
+1,139
| New | +$395K |
|
38
PUT
Boeing
BA
$166B
| $361K | 0.08% |
+1,983
| New | +$353K |
|
39
PUT
Oracle
ORCL
$414B
| $275K | 0.06% |
+1,949
| New | +$242K |
|
40
PUT
Visa
V
$700B
| $272K | 0.06% |
+1,038
| New | +$285K |
|
41
PUT
Summit Therapeutics
SMMT
$14.8B
| $110K | 0.02% |
+14,059
| New | +$75.9K |
|
|
42
Apple
AAPL
$4.88T
| – | – |
-428,061
| Closed | -$79.8M |
|
|
43
AbbVie
ABBV
$463B
| – | – |
-8,524
| Closed | -$1.41M |
|
|
44
Abbott
ABT
$178B
| – | – |
-6,817
| Closed | -$723K |
|
45
Adobe
ADBE
$105B
| – | – |
-24,835
| Closed | -$12M |
|
46
Advanced Micro Devices
AMD
$812B
| – | – |
-70,242
| Closed | -$11.3M |
|
|
47
Amazon
AMZN
$2.75T
| – | – |
-151,026
| Closed | -$27.7M |
|
48
AstraZeneca
AZN
$254B
| – | – |
-9,407
| Closed | -$1.42M |
|
|
49
Boeing
BA
$166B
| – | – |
-2,495
| Closed | -$445K |
|
50
Booking.com
BKNG
$131B
| – | – |
-52,950
| Closed | -$7.84M |
|
Similar funds
MA
WAS
SA
NC
HWMG
MAV
OMIC
SCA
Bender Robert & Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Bender Robert & Associates held 84 positions worth $455M, up 6.7% from $427M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Bender Robert & Associates withdrew a net $433M in Q2 2024, closing 43 positions. Its most notable exit was Apple, an estimated $79.8M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, followed by Communication Services and Consumer Discretionary.
- Bender Robert & Associates fully exited Apple in Q2 2024, selling an estimated $79.8M.
- Bender Robert & Associates's ten largest holdings make up 76% of its $455M portfolio in Q2 2024.
- Bender Robert & Associates opened 41 new positions and closed 43 in Q2 2024.
- Bender Robert & Associates's portfolio value rose 6.7% quarter-over-quarter to $455M.
Based on Bender Robert & Associates's 13F filing for Q2 2024, filed 30 Jul 2024.